Anti-atherogenic effects of fibrates in type 2 diabetes

Type 2 diabetes is an increasing cause of premature coronary heart disease. Several trials with lipid-modifying therapy have included sufficient numbers of diabetics...2型糖尿病（Type 2 diabetes）是早发性冠心病日益重要的致病因素。多项针对调脂治疗（lipid-modifying therapy）的临床试验已纳入足够数量的糖尿病患者……